Fate Therapeutics, Inc. (FATE) Stock Overview
NASDAQ · Healthcare · Biotechnology
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Fate Therapeutics, Inc.
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders in the United States and internationally. The company's chimeric antigen receptor (CAR)-targeted NK and T-cell product candidates include FT836 which…
Source: Yahoo Finance
Sector & Industry
Fate Therapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry group. It is listed on the NASDAQ exchange.
Fate Therapeutics, Inc. at a Glance
| Company | Fate Therapeutics, Inc. |
| Ticker | FATE |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $2.48 |
| Market cap | $297.15M |
| P/E ratio (trailing) | — |
| EPS (trailing) | -$1.05 |
| 52-week high | $3.23 |
| 52-week low | $0.93 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 2.55 |
| Return on equity (ROE) | -60.75% |
| Debt-to-equity | 49.32% |
| Average volume | 2.85M |
| Shares outstanding | 119.82M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 161 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Frequently Asked Questions
- What is Fate Therapeutics, Inc.'s current P/E ratio?
- Fate Therapeutics, Inc. (FATE) has a trailing P/E ratio of — as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Fate Therapeutics, Inc.'s market capitalisation?
- Fate Therapeutics, Inc.'s market cap is $297.15M based on our latest snapshot. See how it ranks by market cap →
- What is FATE's 52-week range?
- Over the past 52 weeks, FATE has traded between $0.93 and $3.23. What does the 52-week range mean? →
- How volatile is Fate Therapeutics, Inc. compared to the market?
- Fate Therapeutics, Inc. has a beta of 2.55, meaning it has historically moved more than the broader market. What does beta measure? →
- Does Fate Therapeutics, Inc. pay a dividend?
- Fate Therapeutics, Inc. does not currently pay a dividend according to our latest data.
- What exchange is FATE listed on?
- FATE is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is Fate Therapeutics, Inc. in?
- Fate Therapeutics, Inc. is classified in the Healthcare sector. Compare with Healthcare peers →
Need to convert currencies or units alongside this data? Our quick conversion tools are always on hand.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Philip Fisher on what makes a business worth owning for the long term.
Check Price →Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →